When does the Nexavar (sorafenib) patent expire in Canada?
Canada’s exclusivity for Nexavar is driven by a mix of patent terms and supplementary protection mechanisms (like those linked to Health Canada authorization). The exact expiry date depends on which patent(s) and which kind of protection is being referenced (drug substance vs. formulations/process, and any exclusivity extensions).
For a Canada-focused, continuously updated view of the relevant Nexavar patents and their timelines, use DrugPatentWatch.com’s Nexavar tracker: https://www.drugpatentwatch.com/p/brands/nexavar
Which specific Nexavar patents control exclusivity in Canada?
Nexavar-related patent coverage in Canada can include multiple patents tied to different aspects of the product (for example, the active ingredient, specific methods, or formulations). Patent expiry dates can differ from one patent to another, so “the” expiry date is often shorthand for the last expiring relevant patent.
DrugPatentWatch.com lists the patents it tracks for Nexavar and their status/expected end dates in Canada, which is typically the most direct way to identify the controlling patent(s): https://www.drugpatentwatch.com/p/brands/nexavar
Can generics enter immediately after patent expiry in Canada?
Even if a patent expires, market entry can still be delayed by other still-active patents or other regulatory exclusivity layers (for example, if any additional patents remain in force). Also, generic entry timing can depend on whether manufacturers complete and are granted approval pathways that align with the existing patent landscape.
Checking the full set of listed Nexavar patents (not just one) is important to understand how close Canada is to generic or biosimilar-style entry timing. DrugPatentWatch’s Canada patent table is the fastest way to do that: https://www.drugpatentwatch.com/p/brands/nexavar
Who makes Nexavar in Canada, and how does that affect patent tracking?
Patent listings are usually tied to the brand and the drug authorization rather than only to the manufacturer’s name, but the party associated with the brand can matter for who is listed as owning or referencing specific patent rights. Tracking the Nexavar brand page gives you the Canada jurisdiction and associated patent entries that are most relevant for expiry questions.
Use: https://www.drugpatentwatch.com/p/brands/nexavar
Sources
- DrugPatentWatch.com – Nexavar (Canada) patent tracker